- Home
- ASRT vs EDAP Comparison
ASRT vs EDAP Comparison
Compare ASRT & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- EDAP
- Stock Information
- Founded
- ASRT 1995
- EDAP 1979
- Country
- ASRT United States
- EDAP France
- Employees
- ASRT N/A
- EDAP N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ASRT Health Care
- EDAP Health Care
- Exchange
- ASRT Nasdaq
- EDAP Nasdaq
- Market Cap
- ASRT 57.9M
- EDAP 53.8M
- IPO Year
- ASRT 1997
- EDAP 1997
- Fundamental
- Price
- ASRT $0.63
- EDAP N/A
- Analyst Decision
- ASRT Strong Buy
- EDAP Buy
- Analyst Count
- ASRT 2
- EDAP 3
- Target Price
- ASRT $3.25
- EDAP $8.50
- AVG Volume (30 Days)
- ASRT 248.2K
- EDAP 37.5K
- Earning Date
- ASRT 08-06-2025
- EDAP 08-27-2025
- Dividend Yield
- ASRT N/A
- EDAP N/A
- EPS Growth
- ASRT N/A
- EDAP N/A
- EPS
- ASRT N/A
- EDAP N/A
- Revenue
- ASRT $119,001,000.00
- EDAP $67,840,467.00
- Revenue This Year
- ASRT N/A
- EDAP N/A
- Revenue Next Year
- ASRT $11.91
- EDAP N/A
- P/E Ratio
- ASRT N/A
- EDAP N/A
- Revenue Growth
- ASRT N/A
- EDAP 3.69
- 52 Week Low
- ASRT $0.51
- EDAP $1.26
- 52 Week High
- ASRT $1.80
- EDAP $5.28
- Technical
- Relative Strength Index (RSI)
- ASRT 53.64
- EDAP 36.07
- Support Level
- ASRT $0.63
- EDAP $1.60
- Resistance Level
- ASRT $0.68
- EDAP $1.74
- Average True Range (ATR)
- ASRT 0.03
- EDAP 0.10
- MACD
- ASRT 0.00
- EDAP -0.01
- Stochastic Oscillator
- ASRT 74.71
- EDAP 27.59
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About EDAP EDAP TMS S.A.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.